Altman Z-Score
0.62
-0.01-1.59%
79 min ago
Summary
- As of February 7, 2025, ORMP Altman Z-Score is 0.62, with the most recent change of -0.01 (-1.59%) on February 7, 2025.
- ORMP current Altman Z-Score indicates the stock has a low bankruptcy risk.
Performance
ORMP Altman Z-Score Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Altman Z-Score Formula
Z-Score = 1.2*A + 1.4*B + 3.3*C + 0.6*D + 1.0*E- A = Working Capital / Total Assets
- B = Retained Earnings / Total Assets
- C = EBIT / Total Assets
- D = Market Cap / Total Liabilities
- E = Revenue / Total Assets
- A = Working Capital / Total Assets
- B = Retained Earnings / Total Assets
- C = EBIT / Total Assets
- D = Market Cap / Total Liabilities
- E = Revenue / Total Assets
ORMP Altman Z-Score Trends
| PeriodPeriod | Altman Z-ScoreAltman Z-Score | PricePrice | Market capMarket cap |
|---|---|---|---|
| todaytoday | -1.6% | -1.8% | -1.8% |
| 1 m1 month | -17.3% | -12.4% | -12.4% |
| 3 m3 months | -8.8% | -6.5% | -6.5% |
| 6 m6 months | -3.1% | -1.8% | -2.6% |
| ytdytd | -16.2% | -11.4% | -11.4% |
| 1 y1 year | -31.1% | -23.6% | -23.6% |
| 5 y5 years | +985.7% | -57.3% | -3.2% |
Oramed Pharmaceuticals Altman Z-Score History
| Date | Value |
|---|---|
| 2025 | 0.62(-16.2%) |
| 2024 | 0.74(+10.4%) |
| 2023 | 0.67(-97.4%) |
| 2022 | 26.19(-9.3%) |
| Date | Value |
|---|---|
| 2021 | 28.89(<-9900.0%) |
| 2019 | -0.10(-70.6%) |
| 2018 | -0.34(-122.1%) |
| 2017 | 1.54(+6.9%) |
| 2016 | 1.44 |
FAQ
- What is Oramed Pharmaceuticals altman z-score?
- What is ORMP altman z-score year-to-date change?
- What is Oramed Pharmaceuticals altman z-score year-on-year change?
What is Oramed Pharmaceuticals altman z-score?
The current altman z-score of ORMP is 0.62
What is ORMP altman z-score year-to-date change?
Oramed Pharmaceuticals altman z-score has changed by -0.12 (-16.22%) since the beginning of the year
What is Oramed Pharmaceuticals altman z-score year-on-year change?
Over the past year, ORMP altman z-score has changed by -0.28 (-31.11%)